Location History:
- Clayton, IN (US) (1985)
- Indianapolis, IN (US) (2006)
Company Filing History:
Years Active: 1985-2006
Title: Innovations and Contributions of Stephen L Briggs
Introduction
Stephen L Briggs is a notable inventor based in Clayton, IN (US). He has made significant contributions to the field of medicine, particularly in the treatment of proliferative diseases. With a total of 5 patents to his name, his work has had a profound impact on cancer treatment and angiogenesis inhibition.
Latest Patents
Among his latest patents, one notable invention is related to methods and compounds for treating proliferative diseases. The compounds disclosed in this patent are indolocarbazoles of Formula (I), which serve as potent CDK4 inhibitors. These compounds are particularly useful in the treatment of cell proliferative disorders, including cancer. Another significant patent involves ascorbic acid ethers in angiogenesis, which includes ethers of ascorbic and isoascorbic acid, as well as ketals and acetals thereof, functioning as angiogenesis inhibitors.
Career Highlights
Stephen L Briggs is currently associated with Eli Lilly and Company, where he continues to innovate and contribute to the pharmaceutical industry. His work at Eli Lilly has allowed him to focus on developing new treatments that address critical health issues.
Collaborations
Throughout his career, Stephen has collaborated with esteemed colleagues such as Gary A Koppel and Russell L Barton. These collaborations have further enhanced the quality and impact of his research and inventions.
Conclusion
In summary, Stephen L Briggs is a distinguished inventor whose work in the field of medicine has led to significant advancements in the treatment of proliferative diseases. His innovative patents and collaborations reflect his commitment to improving healthcare outcomes.